Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
MOTS-c structure

MOTS-c

Other
Phase 1 Research
25%
Moderate Risk
3/5

Dosing Protocol

Typical Dose 5 mg
Range 5 - 10 mg
Maintenance 5 mg 2-3x weekly

Pharmacokinetics

Half-Life 30 min
Onset 15 min
Peak 1.0 hrs
Duration 4.0 hrs
Bioavailability 80%
Primary Route Subcutaneous

Administration

Routes Subcutaneous
Injection Sites Abdomen
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Fasted

Reconstitution

Diluent Bacteriostatic Water
Volume 1 mL
Stability 1 days refrigerated
Vial Sizes 5, 10 mg

Special Instructions

HIGHLY UNSTABLE - degrades 85-90% in 2-3 hours at room temp. Keep frozen until use. Reconstitute immediately before injection.